Jundishapur Journal of Health Sciences

Jundishapur Journal of Health Sciences

Prevalence of Comorbidity of Diabetes and Cardiovascular Disease History in the Shahrekord Cohort Study

Document Type : Research Article

Authors
1 School of nursing, gerash university of medical sciences, gerash, Iran.
2 Assistant Professor of Biostatistics Department of Epidemiology and Biostatistics, School of Health Shahrekord University of Medical Sciences
3 Department of Epidemiology and Biostatistics, School of Health Shahrekord University of Medical Sciences
4 Department of Public Health, Faculty of Science, Eghlid Branch, Islamic Azad University, Eghlid, Iran.
Abstract
Abstract
  Background:The prevalence and incidence of diabetes and cardiovascular diseases (CVD) have been increasing in the past few decades. Determining the prevalence of these diseases helps in the early diagnosis of people at risk, facilitates prevention efforts, and helps reduce the disease burden, mortality, and potential economic impacts on individuals, families, healthcare systems, and society.
 ObjectivesThis study aims to determine the prevalence of comorbidity between diabetes and a history of CVD in the Shahrekord Cohort Study participants.

Methods:  This descriptive comorbidity sub-study included 10,075 participants from the registration phase of the Shahrekord Cohort Study. Data were analyzed using SPSS version 26.
 
Results: The overall prevalence of comorbidity between diabetes and a history of cardiovascular diseases (CVD) was 55.58 per 1,000 participants (95% CI: 51.11–60.05). The comorbidity was found to be highest among several subgroups, specifically: women, illiterate individuals, those who were widowed or divorced, retirees, and individuals with a family history of the disease in first-degree relatives, as well as urban residents. 
ConclusionKnowledge of the prevalence of diabetes, CVD, and comorbidity of these diseases and the associated risk factors in the community is essential for developing medical strategies to interrupt the progression from one disease to comorbidity. Early intervention in the treatment and control of diabetes or common risk factors may prevent the onset of CVD and vice versa.
Keywords

1. NCD Countdown 2030 collaborators. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. Lancet. 2018 Sep 22;392(10152):1072-1088. doi: 10.1016/S0140-6736(18)31992-5. ]PMID[
 .2World Health Organization. Non-communicable disease prevention and control: a guidance note for investment cases. Geneva: World Health Organization; 2019.
 .3 Budreviciute A, Damiati S, Sabir DK, Onder K, Schuller-Goetzburg P, Plakys G, et al. Management and prevention strategies for non-communicable diseases (NCDs) and their risk factors. Front Public Health. 2020;8:788. http://doi.org/10.3389/fpubh.2020.574111. ]PMID[
 .4 Khorrami Z, Rezapour M, Etemad K, Yarahmadi S, Khodakarim S, Mahdavi Hezaveh A, et al. The patterns of non-communicable disease multimorbidity in Iran: a multilevel analysis. Sci Rep. 2020;10(1):1-11.http://doi.org/10.1038/s41598-020-59668-y. ]PMID[
.5 Duceppe E, Parlow J, MacDonald P, Lyons K, McMullen M, Srinathan S, et al. Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery. Can J Cardiol. 2017 Jan;33(1):17-32. doi: 10.1016/j.cjca.2016.09.008. http://doi.org/10.1016/j.cjca.2016.09.008. ]PMID[
.6Ghasemi Ghale Ghasemi SM, Sadeghi R, Tol A, Mirzaei H, Hassanzadeh Aghasemi. Assessing the effect of educational intervention on cardiovascular risk factors prevention among girl students of secondary course in high school: Application of Social Cognitive Theory. J Nurs Educ. 2017:26-37. Available from: https://jne.ir/browse.php?a_id=814&sid=1&slc_lang=en
.7Thagizadeh A, Ghahramanian A, Zamanzadeh V, Aslanabadi N, Onyeka TC, Ramazanzadeh N. Illness perception and cardiovascular risk factors in patients with myocardial infarction undergoing percutaneous coronary intervention in Iran. BMC Cardiovasc Disord. 2022;22(1):245.http://doi.org/10.1186/s12872-022-02684-9. ]PMID[
.8 Zeyfang A, Wernecke J, Bahrmann A. Diabetes Mellitus at an Elderly Age. Exp Clin Endocrinol Diabetes. 2023 Feb;131(1-2):24-32. doi: 10.1055/ a-1946-3728. http://doi.org/10.1055/a-1946-3728. ]PMID[ .9 Asogwa OA, Boateng D, Marzaà-Florensa A, Peters S, Levitt N, van Olmen J, et al. Multimorbidity of non-communicable diseases in low-income and middle-income countries: a systematic review and meta-analysis. BMJ Open.2022;12(1):e049133.https://doi.org/10.1136/bmjopen-2021-049133. 
 .10Zarei H, Norasteh AA, Koohboomi M. The relationship between muscle strength and range of motion in lower extremity with balance and risk of falling in elderlies. Phys Treatments-Spec Phys Ther J. 2020;10(1):33-40. Available from; https://ptj.uswr.ac.ir/browse.php?a_id=415&sid=1&slc_lang=en
.11 Ntiyani N, Letamo G, Keetile M. Prevalence of and factors associated with hypertension, diabetes, stroke and heart attack multimorbidity in Botswana: evidence from STEPS 2014 survey. PLoS One. 2022;17(3):e0265722. http://doi.org/10.1371/journal.pone.0265722 ]PMID[
 .12Zheng B, Su B, Udeh-Momoh C, Price G, Tzoulaki I, Vamos E, et al. Associations of cardiovascular and non-cardiovascular comorbidities with dementia risk in patients with diabetes: results from a large UK cohort study. J Prev Alzheimers Dis. 2022;9(1):86-91.https://doi.org/10.14283/jpad.2022.8 . ]PMID[
.13Rahimian E. Risk factors for cardiovascular complications in patients with type II diabetes: predictive role of psychological factors, social factors and disease characteristics. J Fundam Ment Health. 2011;13(51):93-278.Availablefrom: https://www.magiran.com/paper/937869
 .14Ma CX, Ma XN, Guan CH, Li YD, Mauricio D, Fu SB. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovasc Diabetol. 2022 May 14;21(1):74. doi: 10.1186/ s12933-022-01516-6.http://doi.org/10.1186/s12933-022-01516-6
 .15 Einarson TR, Acs A, Ludwig C, Panton UH. Economic burden of cardiovascular disease in type 2 diabetes: a systematic review. Value Health. 2018;21(7):881-90. http://doi.org/10.1016/j.jval.2017.12.019. ]PMID[
 .16Glovaci D, Fan W, Wong ND. Epidemiology of diabetes mellitus and cardiovascular disease. Curr Cardiol Rep. 2019;21:1-8.http://doi.org/10.1007/s11886-019-1107-y. ]PMID[
 .17Jackson CA, Dobson AJ, Tooth LR, Mishra GD. Lifestyle and socioeconomic determinants of multimorbidity patterns among mid-aged women: a longitudinal study. PLoSOne. 2016;11(6):e0156804.http://doi.org/10.1371/journal.pone.0156804. ]PMID[
.18 Xu X, Mishra GD, Dobson AJ, Jones M. Progression of diabetes, heart disease, and stroke multimorbidity in middle-aged women: a 20-year cohort study. PLoS Med. 2018;15(3):e1002516.https://doi.org/10.1371/journal.pmed.1002516.]PMID[
.19 Khaledifar A, Hashemzadeh M, Solati K, Poustchi H, Bollati V, Ahmadi A, et al. The protocol of a population-based prospective cohort study in southwest of Iran to analyze common non-communicable diseases: Shahrekord cohort study. BMC Public Health. 2018;18:1-10.https://doi.org/10.1186/s12889-018-5364-2 . ]PMID[
.20Shakeri MT, Yousefi R, Alizadeh M, Tireh H, Esmaily H. Application of bivariate logistic regression model in the determination of factors associated with diabetes and hypertension for 35-65 aged people in Mashhad. Navid No. 2019;22(71):30-40.https://doi.org/10.22038/nnj.2019.41739.1171
.21Moghaddas F, Khamnian Z. The prevalence of obesity, hypertension, diabetes and hyperlipidemia among elderlies over 60 years of age of Sahlan area in Tabriz. Depict Health. 2018.Available from: https://doh.tbzmed.ac.ir/Article/doh-230
.22Quinñones AR, Markwardt S, Botoseneanu A. Diabetes-multimorbidity combinations and disability among middle-aged and older adults. J Gen Intern Med. 2019;34:944-51.https://doi.org/10.1007/s11606-019-04896-w .]PMID[
.23Chu Z, Xu B, Liang J. Direct application of carbon nanotubes (CNTs) grown by chemical vapor deposition (CVD) for integrated circuits (ICs) interconnection: challenges and developments. Nanomaterials (Basel). 2023;13(20).https://doi.org/10.3390/nano13202791. ]PMID[